CAS 2012607-27-9

WNK463

CAS: 2012607-27-9

Formula: C₂₁H₂₄F₃N₇O₂

Purity: 96%

Color and Shape: Solid

Molecular weight: 463.4562

Ref: IN-DA00BF83

N-(Tert-Butyl)-1-(1-(5-(5-(Trifluoromethyl)-1,3,4-Oxadiazol-2-Yl)Pyridin-2-Yl)Piperidin-4-Yl)-1H-Imidazole-5-Carboxamide

CAS: 2012607-27-9

N-(Tert-Butyl)-1-(1-(5-(5-(Trifluoromethyl)-1,3,4-Oxadiazol-2-Yl)Pyridin-2-Yl)Piperidin-4-Yl)-1H-Imidazole-5-Carboxamide

Purity: 98%

Molecular weight: 463.46g/mol

Ref: 54-PC108483

WNK463

CAS: 2012607-27-9

WNK463

Purity: ≥95%

Molecular weight: 463.46g/mol

Ref: 54-BUP03316

WNK463

CAS: 2012607-27-9

WNK463 is a pan-WNK-kinase inhibitor. It effectively inhibits the in vitro kinase activity of all four WNK family members (WNK1/2/3/4).

Formula: C₂₁H₂₄F₃N₇O₂

Purity: >99.99% - ≥95%

Color and Shape: Solid

Molecular weight: 463.46

Ref: TM-T7017

WNK463 monohydrate

CAS: 2012607-27-9

A pan-WNK kinase inhibitor, acting on WNK1, WNK2, WNK3, and WNK4 kinases. Affects blood pressure, heart rate, body fluid and electrolyte homeostasis in rodent models of hypertension.

Formula: C₂₁H₂₄F₃N₇O₂·H₂O

Purity: Min. 95%

Color and Shape: Solid

Molecular weight: 481.47 g/mol

Ref: 3D-BW164081